The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers

Journal of Clinical Pharmacology

Volumn 36, Issue 7, 1996, Pages 659-666

  Zhi, Jianguo ^a   Melia, Angela T ^a   Guerciolini, Roberto ^a   Koss Twardy, Susan G ^a   Passe, Sharon M ^a   Rakhit, Ashok ^a   Sadowski, James A ^b  

^a HOFFMANN LA ROCHE INC   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; TETRAHYDROLIPSTATIN; VITAMIN K GROUP; WARFARIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; HUMAN; INTESTINE ABSORPTION; MALE; ORAL DRUG ADMINISTRATION; PROTHROMBIN TIME;

EID: 0029762746     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04232.x     Document Type: Article

References (21)

1. Hadvàry P, Lengsfeld H, Wolfer H: Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. Biochem J 1988; 256:357-361.
2. Borgström B: Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin. Biochim Biophys Acta 1988; 962:308-316.
3. Fernandez E, Borgström B: Effects of tetrahydrolipstatin, a lipase inhibitor, on absorption of fat from the intestine of the rat. Biochim Biophys Acta 1989; 1001:249-255.
4. Zhi J, Melia AT, Guerciolini R, Chung J, Kinberg J, Hauptman JB, Patel IH: Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlislat in normal and obese volunteers. Clin Pharmacol Ther 1994; 56:82-85.
5. Persson AV, Davis RJ, Villavicencio JL: Deep venous thrombosis and pulmonary embolism. Surg Clin North Am 1991; 71:1195-1209.
6. Porter RS, Sawyer WT: Warfarin. In, Evans WE, Schentag JJ, Jusko WJ (eds.): Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. Third edition. Vancouver, WA: Applied Therapeutics, 1992;31-1-31-46.
7. Ferland G, Sadowski JA, O'Brien ME: Dietary induced subclinical vitamin K deficiency in normal human subjects. J Clin Invest 1993; 91:1761-1768.
8. Zhi J, Melia AT, Eggers H, Joly R, Patel IH: Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers. J Clin Pharmacol 1995; 35:1103-1108.
9. 1 (phylloquinone) content of foods: a provisional table. J Food Composition Anal 1993; 6:109-120.
10. Banfield C, Rowland M: Stereospecific high-performance liquid chromatographic analysis of warfarin in plasma. J Pharm Sci 1983; 72:921-924.
11. Sutfin T, Balmer K, Bostrom H, Eriksson S, Hoglund P, Paulsen O: Stereoselective interaction of omeprazole with warfarin in healthy men. Ther Drug Monit 1989; 11:176-184.
12. 1 in plasma, with fluorometric detection. Clin Chem 1986; 32:1925-1929.
13. Sokoll LJ, O'Brien ME, Camilo ME, Sadowski JA: Undercarboxylated osteocalcin and development of a method to determine vitamin K status. Clin Chem 1995; 41:1121-1128.
14. Grizzle JE: The two-period change-over design and its use in clinical trials. Biometrics 1965; 21:467-480.
15. Grizzle JE: Corrections to the two-period change-over design and its use in clinical trials. Biometrics 1974; 30:727.
16. Pitsiu M, Parker EM, Aarons L, Rowland M: Population pharmacokinetics and pharmacodynamics of warfarin in healthy young adults. Eur J Pharm Sci 1993; 1:151-157.
17. Nagashima R, O'Reilly RA, Levy G: Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin. Clin Pharmacol Ther 1969; 10:22-35.
18. Price PA, Kaneda Y: Vitamin K counteracts the effect of warfarin in liver but not in bone. Thromb Res 1987; 46:121-131.
19. Vermeer C, Jie K-SG, Knapen MHJ: Role of vitamin K in bone metabolism. Annu Rev Nutr 1995; 15:1-22.
20. Usui Y, Tanimura H, Nishimura N, Kobayashi N, Okanoue T, Ozawa K: Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr 1990; 51:846-852.
21. Nakamura K, Toyohira H, Kariyazono H, Ishibash M, Saigenji H, Shimokawa S, Taira A: Anticoagulant effects of warfarin and kinetics of K vitamins in blood and feces. Artery 1994; 21:148-160.